Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

This study has been completed.
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: February 19, 2003
Last updated: October 14, 2014
Last verified: October 2014